General information

Announcements(0)

Program

Sessions

Search presentations

Timetable

Wed. Dec 3, 2025

Thu. Dec 4, 2025

Fri. Dec 5, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Download PDF for print

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

Please enter the password printed on your name card.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

<em>Drosophila</em>-Based Human Cancer Xenograft Model and Perspectives for Drug Discovery Applications

Nowadays, as academia has become more prevalent in drug discovery, many seeds that are new to academia have been generated. However, it is also true that only about 1% of these seeds result in joint research. This gap is largely due to the awareness of both parties regarding drug discovery. In order to bridge this gap, attention is being paid to needs, i.e. the voice of patients. It will be difficult to overcome difficult diseases unless we build a system that is sensitive to needs, respects each other, and works together to advance development. This conference will deepen the discussion by focusing on pharmaceutical and technological development that focuses on medical needs, and explore the path to drug discovery that can be created jointly between academia and companies.

【J】Academic Drug Development Conference 2025

The 48th Annual Meeting of the Molecular Biology Society of Japan

Presentation Information

[2PS-09-03]Drosophila-Based Human Cancer Xenograft Model and Perspectives for Drug Discovery Applications

Comment